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Background: Outcomes of revascularization for critical limb ischemia (CLI) have historically been patency, limb salvage,
and survival. Functional status and quality of life have not been well described. This study used functional and quality of
life assessments to measure patient-centered outcomes after revascularization for CLI.
Methods: The study observed 18 patients (age, 65 6 11 years) prospectively before and after lower extremity bypass for
CLI. Patients completed the Short Physical Performance Battery, which measures walking speed, leg strength, and
balance, as well as performed a 6-minute walk, and calorie expenditure was measured by an accelerometer. Isometric
muscle strength was assessed with the Muscle Function Evaluation chair (Metitur, Helsinki, Finland). Quality of life
instruments included the 36-Item Short Form Health Survey and the Vascular Quality of Life questionnaire. Patients’
preoperative status was compared with 4-month postoperative status.
Results: Muscle Function Evaluation chair measurements of ipsilateral leg strength demonstrated a signiﬁcant increase in
knee ﬂexion from 64 6 62 N to 135 6 133 N (P [ .038) and nearly signiﬁcant increase in knee extension from 120 6
110 N to 186 6 85 N (P [ .062) and ankle plantar ﬂexion from 178 6 126 N to 267 6 252 N (P [ .078). In the
contralateral leg, knee ﬂexion increased from 71 6 96 N to 149 6 162 N (P [ .028) and knee extension from 162 6
112 N to 239 6 158 N (P [ .036). Absolute improvements were noted in 6-minute walk distance, daily calorie
expenditure, and individual domains and overall Short Physical Performance Battery scores, and upper extremity strength
decreased, although none were signiﬁcant. The Vascular Quality of Life questionnaire captured signiﬁcant improvement
in all individual domains and overall score (P < .015). Signiﬁcant improvement was noted only for bodily pain (P[ .011)
on the 36-Item Short Form Health Survey.
Conclusions: Despite lack of statistical improvement in most functional test results, revascularization for CLI results in
improved patient-perceived leg function. Signiﬁcant improvements in isometric muscle strength may explain the
measured improvement in quality of life after revascularization for CLI. (J Vasc Surg 2014;60:136-42.)Peripheral arterial disease (PAD) has become increas-
ingly prevalent in this country as the population ages and
the accumulation of risk factors, such as diabetes and smok-
ing, is manifested. A fraction of patients with PAD will
progress to critical limb ischemia (CLI) and will often
require an intervention to salvage the limb. The success
of an intervention has historically been oriented toward
assessment of the results of the operation (ie, procedural
patency and limb salvage), without considering how the
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://dx.doi.org/10.1016/j.jvs.2014.01.067studies have investigated the effects of surgery on self-
reported ambulatory and living status,1,2 which, although
important end points, still do not completely address
patients’ physical functioning and quality of life.
Treatment of peripheral vascular disease carries a signif-
icant burden for the patient and health care system alike.
The paucity of literature on functional outcomes for this
group led the TransAtlantic Inter-Society Consensus to
state that “speciﬁc instruments capable of detecting
improvement in functional status in this [CLI] population
must be developed.”3 At present, there is no consensus on
the appropriate tools for assessing functional and quality of
life outcomes for patients who undergo a limb salvage pro-
cedure for CLI.
A previous review discussed how quality of life ques-
tionnaires and functional measurements that had been vali-
dated for PAD could be adapted for patients with CLI for
assessment of changes occurring during the preoperative
and postoperative interval.4 These included previously vali-
dated questionnaires (36-Item Short Form Health Survey
[SF-36], Vascular Quality of Life [VascuQol], and Geri-
atric Depression Scale) and a battery of physical tests
including timed 6-minute walk, summary performance
test (chair raises, balance, and 4-meter walk), daily calorie
expenditure, and upper and lower extremity isometric mus-
cle strength measured by the Muscle Function Evaluation
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experience with a mix of self-reported and objective assess-
ment tools in a cohort of patients enrolled in a longitudinal
study for outcomes after surgical intervention for CLI.
METHODS
The study was approved by the Institutional Review
Board at the Oregon Health & Science University. Patients
were recruited from the vascular surgery clinic at the Ore-
gon Health & Science University. Study entry was offered
to all patients undergoing surgical bypass for CLI from
January 2007 to January 2009. Patients who were nonam-
bulatory before the onset of CLI were excluded.
All patients underwent standard vascular bypasses with
autogenous conduit. Functional and quality of life assess-
ments were performed preoperatively and at approximately
4 months postoperatively, depending on patients’ ability to
return to the investigation site.
A series of functional assessments were performed by
tests previously validated in the population of patients
with PAD, although not speciﬁcally for patients with CLI.
Walking distance. The timed 6-minute walk has been
validated as a means to evaluate leg function and exercise
capacity in the elderly and PAD populations.5,6 The test is
performed in a 100-foot-long ﬂat hallway. Patients are
instructed to walk back and forth as far as they can in
6 minutes. Trained personnel walk directly behind the
subjects and give standardized instructions of encourage-
ment at set intervals. Subjects determine their own pace
and stop and rest, if needed. The total distance covered is
recorded in linear meters. Because subjects are allowed to
walk at their own pace, results of a 6-minute walk are a
more accurate reﬂection of walking abilities, and the test is
less anxiety-provoking than treadmill walking.7
Summary performance score. The summary perfor-
mance score is derived from three tests: a timed 4-meter
walk, the Tinetti balance test, and a timed test of muscle
power in which patients stand and sit repetitively ﬁve times.
These tests have been validated in a number of populations,
such as stroke and geriatric patients.8,9 The timed 4-meter
walk consists of two separate trials in which the patient
walks in a straight line at a brisk pace for 4 meters. The
faster of the two trials is recorded. The Tinetti balance
equation is a well-established assessment of balance in
predicting mobility in the elderly as well as in functionally
impaired patients.10 Patients stand with their feet in three
separate positions: side by side, in semi-tandem, and in
tandem. Scores are assigned on the basis of the number of
seconds that patients can hold each position, from 0 to
10 seconds. The sit-stand test is a validated test for muscle
strength and function in the elderly and is predictive of
need for nursing home care.8,9 Patients begin seated and
are timed while they perform ﬁve repetitions of standing
and sitting down. For each task, a score (1-4, with 4 being
the highest) is assigned, and the cumulative score is tabu-
lated according to an established scoring rubric.
Physical activity. The Caltrac vertical accelerometer is
a validated measure of physical activity and is used toestimate daily activity level. Patients wore the accelerom-
eter for 5 days, and their daily activity was calculated as a
total calorie expenditure and averaged to estimate a daily
expenditure. This value approximates patient function
outside of the clinic, in the setting of daily life and in the
community.11-13
Isometric muscle strength. The Muscle Function
Evaluation chair was designed for use in the setting of
physical rehabilitation and ﬁtness training. Transducers
measure isometric strength in newtons in multiple muscle
groups Patients were seated upright in the chair with one
extremity strapped into the chair at a time. Adjustable
seat back and arm and leg restraints allowed the chair to
be ﬁtted individually, such that muscle function could be
evaluated in the most comfortable position. There are
four force transducers located on the chair that measure
strength at the elbow, knee, and talocrural joints as well
as hand grip strength with isometric muscle contractions.
Patients had 10 seconds to generate their maximum force
possible, with 10-second rest periods in between. The
largest value during those 10 seconds was recorded as a
peak force in newtons. Upper extremity function was
evaluated in addition to lower extremity function as a sur-
rogate evaluation of overall postoperative deconditioning.
Quality of life questionnaires. A number of self-
administered questionnaires are available to assess gener-
alized and disease-speciﬁc quality of life. A combination of
the two types of questionnaires is often employed to cap-
ture quality of life impairment due to a speciﬁc disease
process vs overall quality of life. The SF-36 is widely used as
a generalized quality of life assessment and has been
thoroughly validated for use in patients with PAD and to a
lesser extent in groups of patients with CLI. The SF-36
considers eight categories of health: physical function,
role limitation due to physical problems, bodily pain,
general health perception, social function, emotional well-
being, and role limitation due to emotional well-being.
The VascuQoL questionnaire was included to capture
disease-speciﬁc health parameters. The VascuQoL asks 25
questions falling into ﬁve broad categories: pain, activity,
emotion, symptoms, and social. Each category is scored
from 1 to 7 points, with 7 being the highest, and the total
is averaged for the ﬁve categories to give a summary
score.14 Finally, the Geriatric Depression Scale was used
in this setting on the basis of association between depres-
sive symptoms and decline in function.15 Scores range
from 1 to 15, based on the number of statements about
personal health with which the patient agrees. A score
above 5 is generally considered to indicate depressive
symptoms.
Study participation was offered to all eligible patients
undergoing surgical revascularization for CLI. Exclusion
criteria included nonambulatory status predating the onset
of CLI and non-English speakers.
Preoperative and postoperative data were compared
by a paired t-test for continuous, normally distributed
data and the Mann-Whitney U test for ordinal data. Statis-
tical signiﬁcance was determined at the P < .05 level.
Table I. Demographic data of the study cohort of 18 patients and 42 nonparticipants
Factor Study patients (n ¼ 18) Nonparticipants (n ¼ 42) Signiﬁcance
Gender, % male 67% 71% NS
Mean age at surgery 6 SD, years 65 6 11 66 6 14 NS
Indication NS
Rest pain 33% 45%
Ulcer or gangrene 67% 55%
Diabetes 67% 48% NS
Hypertension 72% 83% NS
Coronary artery disease 44% 48% NS
Smoking history 72% 62% NS
Hypercholesterolemia 78% 52% NS
Renal insufﬁciency (Cr > 1.5) 11% 17% NS
Dialysis dependence 6% 7% NS
COPD 17% 14% NS
Previous ipsilateral bypass 39% 55% NS
Type of bypass NS
Femoral-popliteal 39% 29%
Femoral-tibial 50% 64%
Popliteal-pedal 11% 7%
COPD, Chronic obstructive pulmonary disease; Cr, creatinine; NS, not signiﬁcant; SD, standard deviation.
Table II. Functional measurements before and after
lower extremity bypass for CLI
Assessment Preoperative Postoperative P value
Daily physical activity,
calories
1773 6 1786 2064 6 1201 .313
Six-minute walk
distance, meters
97 6 88 128 6 75 .216
Four-meter walk scorea 2.43 6 1.4 2.50 6 1.5 .849
Standing balancea 2.36 6 1.8 2.86 6 1.5 .510
Chair risesa 1.47 6 1.4 2.00 6 1.7 .417
Overall SPPB scorea 6.36 6 4 7.21 6 4 .849
CLI, Critical limb ischemia; SPPB, Short Physical Performance Battery.
aScored 0 to 4. Overall score, 0 to 12: 0, worst; 12, best (reported as
mean 6 standard deviation). Each measurement scored is based on estab-
lished quartiles for the elderly population.
Table III. Lower extremity isometric muscle strength in
the treated extremity
Ipsilateral measurement Preoperative Postoperative P value
Ankle dorsiﬂexion 124 6 87 130 6 98 .826
Ankle plantar ﬂexion 178 6 126 267 6 252 .078
Knee ﬂexion 64 6 62 135 6 133 .038
Knee extension 120 6 110 186 6 85 .062
Reported in newtons (mean 6 standard deviation).
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During the study period, 18 subjects were enrolled and
completed both preoperative and postoperative assess-
ments. Six patients had rest pain, whereas 12 had ulcers
or gangrene. All underwent vein bypass with autologous
conduit (7 femoralebelow-knee popliteal, 9 femoral-
tibial, 2 popliteal-pedal). Five patients underwent digital
amputations during the follow-up period, all of which
healed, with no major amputations. The mean length of
follow-up at the second evaluation was 121 6 57 days.
During the same period, 60 bypasses were performed in
eligible patients. Six patients enrolled and completed the
preoperative assessment but refused the postoperative
assessment; 36 declined participation. Incomplete partici-
pants and nonparticipants cited travel distance and time
commitment as reasons for refusal. There were no demo-
graphic differences between participants and nonpartici-
pants (Table I).
There was a signiﬁcant increase in ankle-brachial index
(ABI) of the treated extremity after surgery (0.46 6 0.17
preoperatively, 0.86 6 0.21 postoperatively; P < .001).
The contralateral ABI was unchanged after surgery
(0.70 6 0.22 preoperatively, 0.76 6 0.16 postoperatively).
All grafts remained patent and no subjects died during the
study period.
The results of the functional studies are presented in
Table II. There was numerical improvement in all of the
parameters tested (daily calorie expenditure, 6-minute walk-
ing distance, 4-meter walking score, Tinetti standing balance
score, repeated chair rises, and overall summary performance
score); however, none reached statistical signiﬁcance.
In contrast, signiﬁcant improvement was noted in
multiple measurements of isometric muscle strength in
both the surgical and contralateral extremities (Tables III
and IV). In the ipsilateral leg, knee ﬂexion improved signiﬁ-
cantly from 64 6 62 N preoperatively to 135 6 133 Npostoperatively (P ¼ .038). Strong trends toward im-
provement were also noted in ankle plantar ﬂexion
(178 6 126 N preoperatively vs 267 6 252 N postopera-
tively; P ¼ .078) and knee extension (120 6 110 N vs
186 6 85 N; P ¼ .062). Signiﬁcant improvements were
also noted in the contralateral limb in knee ﬂexion (71 6
96 N preoperatively vs 149 6 162 N postoperatively; P ¼
.028) and knee extension (162 6 112 N preoperatively
vs 2396 158 N postoperatively; P¼ .036). No signiﬁcant
changes in upper extremity function were noted (Table V).
Table V. Upper extremity isometric muscle strength
Upper extremity
measurement Preoperative Postoperative P value
Right elbow ﬂexion 160 6 97 143 6 64 .322
Left elbow ﬂexion 114 6 74 137 6 74 .272
Right elbow extension 118 6 63 109 6 60 .662
Left elbow extension 108 6 77 107 6 61 .981
Right hand grip 266 6 140 236 6 128 .199
Left hand grip 261 6 149 220 6 138 .253
Reported in newtons (mean 6 standard deviation).
Table VI. Quality of life before and after surgery
(generalized, not disease speciﬁc)
SF-36
Preoperative
scorea
Postoperative
scorea P value
Physical functioning 30 6 23 45 6 30 .172
Role limitations due
to physical health
4 6 13 29 6 42 .067
Bodily pain 25 6 19 45 6 21 .001
General health 49 6 21 54 6 14 .36
Vitality 42 6 19 46 6 19 .532
Social functioning 47 6 28 58 6 27 .151
Role limitations
due to emotional
problems
57 6 50 65 6 43 .675
Mental health 69 6 19 76 6 14 .246
SF-36, 36-Item Short Form Health Survey.
aScored 0 to 100 (reported mean6 standard deviation): 0, worst; 100, best.
Table VII. Quality of life before and after surgery
(disease speciﬁc)
VascuQol Preoperative scorea Postoperative scorea P value
Activity 2.32 6 0.95 4.04 6 1.44 .001
Symptoms 3.35 6 1.38 5.22 6 1.14 .001
Pain 2.53 6 1.06 4.45 6 1.83 .002
Emotional 3.60 6 1.33 5.06 6 1.37 .014
Social 2.84 6 1.50 5.09 6 1.45 .001
Total score 2.93 6 0.93 4.66 6 1.28 .001
VascuQol, Vascular Quality of Life questionnaire.
aScored 1 to 7 (reported mean 6 standard deviation): 1, worst; 7, best.
Table IV. Lower extremity isometric muscle strength in
the contralateral extremity
Contralateral measurement Preoperative Postoperative P value
Ankle dorsiﬂexion 163 6 109 150 6 93 .624
Ankle plantar ﬂexion 252 6 182 292 6 252 .368
Knee ﬂexion 71 6 96 149 6 162 .028
Knee extension 162 6 112 239 6 158 .036
Reported in newtons (mean 6 standard deviation).
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a signiﬁcant improvement was seen only in the domain of
bodily pain (preoperative score, 25 6 19; postoperative
score, 45 6 21; P ¼ .001), with a strong trend toward
improvement in role limitations due to physical health (pre-
operative score, 4 6 13; postoperative score, 29 6 42;
P ¼ .067). No differences were noted in the domains of
physical functioning, general health, vitality, social func-
tioning, role limitations due to emotional problems, or
mental health (Table VI).
In the disease-speciﬁc quality of life questionnaire (Vas-
cuQol), signiﬁcant improvements were noted in all do-
mains and in the total score (Table VII). There was no
signiﬁcant change in the Geriatric Depression Scale score
(preoperative score, 4.1 6 3.8; postoperative score,
4.9 6 2.9; P ¼ .394). Four subjects (22.2%) had clinically
signiﬁcant depression scores ($6), with no signiﬁcant
change after revascularization.
DISCUSSION
Assessment of functional outcomes of surgical revascu-
larization for CLI has undergone a signiﬁcant evolution
in the past two decades. For many years, the outcomes
of surgical revascularization for CLI were reported as
graft patency, limb salvage, and survival. These remain
important parameters as good leg function is dependent on
optimal perfusion. However, graft patency tends to be a
“lesion-oriented” outcome measure and may not reﬂect
how well a patient is performing functionally. In the
1990s, the emphasis of outcomes reporting shifted to more
“patient-oriented” outcomes.1,2 Ambulatory status and
living status (ie, independent vs nonindependent living)
were reported, and self-reported quality of life assessments
became standard reporting measures. Numerous studieshave subsequently conﬁrmed functional improvements in
the majority of patients on the basis of these measures.16-19
However, graft patency does not always translate to
good function. A recent study from the Vascular Surgery
Group of New England demonstrated that 10% of patients
experienced clinical failure at 1 year after bypass, deﬁned as
amputation or worsening ischemia, despite having a patent
graft.20 Taylor21 deﬁned clinical success as graft patency to
the point of wound healing, limb salvage, and ambulation
for 1 year after bypass and survival for 6 months. Only 44%
of 331 consecutive bypass patients were able to achieve
clinical success.
The use of ambulatory status and living status as
outcome measures makes assumptions that may not be
true for all patients. Whereas independent ambulation is a
desirable outcome to preserve, as a binary variable it leaves
many unanswered questions about the duration or quality
of ambulation, and it does not assess how patients perform
in their activities of daily living. Kumar22 demonstrated that
although revascularization allowed preservation of ambula-
tory function, only 53% of working patients were able to re-
turn to their original work. Likewise, whereas independent
living is preferable for most people, a high level of function-
ality is certainly possible in an assisted living environment.
Self-reported quality of life questionnaires also are inher-
ently ﬂawed in that they rely on patients’ perceptions and
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As stated by the Nobel Prize-winning psychologist Daniel
Kahneman, when one is asked about quality of life, “A
few ideas that are relevant to the question will occur to
you; many others will not . the score that you quickly
assign to your life is determined by a small sample of highly
available ideas, not by a careful weighting of the domains of
your life.”23
The lack of a validated functional assessment tool to
evaluate interventions for CLI was cited in the TransAt-
lantic Inter-Society Consensus I document as a critical issue
for further research. In this study, we used a battery of
functional assessments that have previously been used
extensively in the assessment of geriatric patients, although
not speciﬁcally to assess the results of intervention.
Quality of life improvements after successful revascular-
ization were noted in this patient population. All domains
of the VascuQol demonstrated signiﬁcant improvements
at 4 months, as did the aggregate score. In the SF-36 anal-
ysis, only the pain domain showed signiﬁcant improve-
ment. These ﬁndings are in line with numerous previous
studies that have shown similar improvements in self-
reported quality of life with use of a variety of general
and disease-speciﬁc quality of life measures, the largest of
which, the Prevention of Recurrent Venous Thromboem-
bolism (PREVENT) III trial, examined more than 1400
subjects.24 In contrast, Cieri et al,25 using the Katz index,
noted a signiﬁcant decline in the ability to perform activ-
ities of daily living after both surgical and endovascular
revascularization, despite successful limb preservation and
improvements in pain relief and tissue healing. McDermott
et al15 noted a high prevalence of depressive symptoms in
patients with symptomatic PAD, with 21.7% of patients
exhibiting signiﬁcant depressive symptoms and a greater
number of depressive symptoms associated with greater
impairment of lower extremity function. In our study, a
similar percentage of patients (22.2%) exhibited signiﬁcant
depressive symptoms but with no signiﬁcant change after
successful revascularization.
Of the objective functional measures performed, the
results of evaluation with the Muscle Function Evaluation
chair correlated best with the self-reported quality of life
ﬁndings. Isometric muscle strength has been found to be
diminished in the distal extremities in patients with PAD
and is correlated with diminished ABI.26 Subjects with
PAD and diminished baseline muscle strength have been
shown to have increased long-term functional decline and
mortality.27,28 The Muscle Function Evaluation chair mea-
sures isometric muscle strength in multiple groups. How
revascularization improves muscle strength is not clear.
Whether actual muscle mass improves is not known. It is
perhaps more likely that improvement in ischemic pain al-
lows better performance. Whereas there was a trend toward
improvement in all of the functional measures, only in the
Muscle Function Evaluation chair did it reach signiﬁcance.
This included signiﬁcant improvements in the contralateral
extremity as well, which suggests an overall deconditioning
with CLI that improves once successful revascularizationoccurs, allowing improvements in both legs. Isometric
movements are more subtle than walking, balance, or po-
wer measurements involving gross movement. Isometric
strength is also perhaps more pertinent to the activities of
a patient with CLI, who may actually spend very little
time walking but needs the ability to perform minor mo-
tions, such as comfortably adjusting positions in a bed or
chair, that rely on isometric strength.
These data were prospectively obtained, which is a
strength of this study in comparison to other functional
assessment tools. Data on the timed walk, accelerometer,
and quality of life assessment are similar to those of Gard-
ner and Killewich,29 who likewise found nonstatistical im-
provements in the functional test results but signiﬁcant
improvements in quality of life. This study differs in the in-
clusion of isometric muscle strength evaluation. The lack of
signiﬁcance in this study as well as in that of Gardner and
Killewich may be due to type II error from small sample
size. It is certainly possible that signiﬁcance would be
achieved in a larger sample size. Alternatively, evaluations
based on walking, although potentially useful for patients
undergoing treatment for intermittent claudication, may
be unsuitable for the patients with CLI.
The weakness of this study lies in its small sample size.
Before the study, we performed a power analysis based on
an expected standard deviation of the difference between
the 6-minute walk results before and after intervention,
which suggested that 96 patients would need to be
recruited to detect a difference of 50 meters with 80% po-
wer at a signiﬁcance of .05. One of the lessons learned from
this study was the difﬁculty in evaluating the group of pa-
tients with CLI. The battery of tests used in this study took
between 2 and 3 hours to complete. Many patients refused
participation in the study because of the time commitment.
It is therefore possible that we have overestimated the
actual functional recovery of all patients with CLI by select-
ing a group that was most highly motivated and compliant
with follow-up.
The short follow-up interval (mean, 4 months) may
also be perceived as a weakness of this study. Our intent
was to observe patients out to 1 year, but the demands
of the testing proved to be too great on the subjects to
allow longer follow-up. However, in both the Bypass vs
Angioplasty in Severe Ischaemia of the Leg (BASIL)30
and PREVENT III trials, quality of life improvements at
3 months did not change signiﬁcantly out to 1 year of
follow-up; therefore, it is reasonable to extrapolate a similar
course in this patient cohort.
National trends in lower extremity revascularization
demonstrate a gradual decrease in the number of surgical
revascularizations with a sharp upswing in the number of
endovascular revascularizations. Currently, the results of
endovascular revascularization are primarily reported in
terms of patency and limb salvage, a reversion to the initial
measures used to determine success of leg bypasses, with
few endovascular trials focusing on functional outcomes.
The results of the BASIL trial indicated equal gains in qual-
ity of life in the surgery and endovascular group out to
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success regardless of revascularization method, with patient
demographic factors, such as end-stage renal disease,
hyperlipidemia, diabetes, and preoperative functional sta-
tus, playing a greater role in determining postoperative
functional status than method of revascularization. It is
clear that quality of life and functional assessment will
need to become an integral part of results reporting for
endovascular procedures32 as well as to patients receiving
best medical therapy, and the measures used in this study
are readily adaptable to assessment of this group.
Measurement of isometric muscle strength is informa-
tive but may not be practical for widespread use. It requires
specialized equipment that may not be widely available
outside of the research setting, but in this regard, we have
found it very useful. Although it would be premature on
the basis of this small study to conclude that isometric
strength measurement should be a part of clinical trials for
CLI, it clearly merits further study and could potentially be
used as a marker for functional and quality of life improve-
ments. However, a larger scale study using themuch simpler
methods of assessment, such as hallway walking, walking
speed, balance, and standing, would be useful to demon-
strate if these measures are indeed signiﬁcant in a larger pa-
tient population. Likewise, the accelerometer is a useful
method of assessing community functioning, but compli-
ance is an issue that is difﬁcult to assess or to prove.
CONCLUSIONS
Successful bypass for CLI results in signiﬁcant improve-
ments in patient-perceived quality of life with use of a
disease-speciﬁc questionnaire (VascuQol) and in the pain
domain of the SF-36. Of the functional parameters
assessed, isometric strength of multiple muscle groups in
both the treated and contralateral leg showed the only sta-
tistically signiﬁcant improvement in this small patient
cohort. Whereas more research is necessary in larger patient
groups and with longer follow-up, isometric muscle mea-
surements should be considered for use as an outcome
measure in clinical trials of revascularization for CLI.
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